VP
Vertex Pharmaceuticals Incorporated
Every trial this sponsor leads in the registry, and everything it has published.
Recruiting13
Recruited13
Not yet recruiting3
By invitation3
Completed202
Stopped25
Other1
32 active · 12% of this sponsor’s registry footprint
Respiratory9 trials
Metabolic/Endocrine/Nutrition7 trials
Renal & Urology6 trials
Haematology4 trials
Neurology2 trials
Immunology & Inflammation1 trial
Pain & Musculoskeletal1 trial
Not shown above: 2 trials whose condition matched no therapy area.
Trials by phase
Phase 1102
Phase 270
Phase 381
Phase 46
Unphased1
Pipeline by phase · 15 drugs in active development
Phase 3 · 5 drugs
Phase 2 · 4 drugs
Phase 1 · 5 drugs
Phase 4 · 1 drug
Active trials only, code names and brands merged. 202 completed trials are in the counts above but their drugs are not folded into this pipeline.
Track your drug now for free
We check every one of its trials daily and tell you what moved.
- Status changeStatus moved to completedWas recruiting · always alerts
- Completion date movePrimary completion slipped 210 daysSlips and pull-ins of 30+ days
- New trialNew trial registered in your scopeFirst posted within 30 days
- Enrollment changeEnrollment grew to 1,200Moves of 15%+ or count finalised
- Substantive record editPrimary endpoint redefined from 24 to 52 weeksRead overnight and flagged in plain English
US registryClinicalTrials.gov
EU registryCTIS · Soon